BioCentury
ARTICLE | Clinical News

AGT-182 regulatory update

January 27, 2014 8:00 AM UTC

The European Commission granted Orphan Drug designation to AGT-182 from ArmaGen to treat mucopolysaccharidosis type II (MPS-II, Hunter's syndrome). The product is slated to enter clinical testing for ...